Explore

Trendline Trendline
GI Partners Acquires CDMO and Cell Solutions from Charles River, Forms Rose BioSolutions

GI Partners Acquires CDMO and Cell Solutions from Charles River, Forms Rose BioSolutions

GI Partners Acquires CDMO and Cell Solutions from Charles River, Forms Rose BioSolutions
Trendline Trendline
Charles River Laboratories Reports First-Quarter 2026 Results with Revenue Increase and Stock Repurchase

Charles River Laboratories Reports First-Quarter 2026 Results with Revenue Increase and Stock Repurchase

Charles River Laboratories Reports First-Quarter 2026 Results with Revenue Increase and Stock Repurchase
Trendline Trendline
Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures

Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures

Charles River Laboratories Reports Q1 2026 Revenue Growth Amid Divestitures
Trendline Trendline
Digital Orchestration Transforms Regulatory Frameworks for Cell and Gene Therapy

Digital Orchestration Transforms Regulatory Frameworks for Cell and Gene Therapy

Digital Orchestration Transforms Regulatory Frameworks for Cell and Gene Therapy
Trendline Trendline
GSK Acquires Chinese siRNA Specialist to Enhance Cardiometabolic Portfolio

GSK Acquires Chinese siRNA Specialist to Enhance Cardiometabolic Portfolio

GSK Acquires Chinese siRNA Specialist to Enhance Cardiometabolic Portfolio
Trendline Trendline
Charles River Laboratories Reports First-Quarter Revenue Increase Amid Divestitures

Charles River Laboratories Reports First-Quarter Revenue Increase Amid Divestitures

Charles River Laboratories Reports First-Quarter Revenue Increase Amid Divestitures
Trendline Trendline
AAVnerGene Launches AAVone®2.1 to Enhance Gene Therapy Manufacturing Efficiency

AAVnerGene Launches AAVone®2.1 to Enhance Gene Therapy Manufacturing Efficiency

AAVnerGene Launches AAVone®2.1 to Enhance Gene Therapy Manufacturing Efficiency
Trendline Trendline
VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Gene Therapy Advances

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Gene Therapy Advances

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Gene Therapy Advances
Trendline Trendline
VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Advances in Gene Therapy

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Advances in Gene Therapy

VectorBuilder to Present on Therapeutic Vector Design at ASGCT 2026, Highlighting Advances in Gene Therapy
Trendline Trendline
BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position

BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position

BioLife Solutions Reports 25% Revenue Increase in Q1 2026, Strengthening Market Position
Trendline Trendline
Bio-Rad Laboratories to Engage in Key Investor Conferences, Highlighting Financial Strategies

Bio-Rad Laboratories to Engage in Key Investor Conferences, Highlighting Financial Strategies

Bio-Rad Laboratories to Engage in Key Investor Conferences, Highlighting Financial Strategies
Trendline Trendline
Arrowhead Pharmaceuticals Reports Strong Growth and New Developments in RNAi Therapeutics

Arrowhead Pharmaceuticals Reports Strong Growth and New Developments in RNAi Therapeutics

Arrowhead Pharmaceuticals Reports Strong Growth and New Developments in RNAi Therapeutics